期刊文献+

TLR4和TLR9mRNA在麻风患者外周血单核细胞中的表达 被引量:3

The Expression of TLR4 and TLR9 mRNA on Peripheral Blood Mononuclear Cells (PBMC) in Patients with Leprosy
下载PDF
导出
摘要 目的观察TLR4和TLR9mRNA在麻风患者外周血单核细胞中的表达情况。方法运用SYBRGreen荧光定量RT-PCR技术检测麻风现症患者(30例)与已痊愈患者(30例)外周血单核细胞中TLR4和TLR9mRNA的表达水平,并与正常人作比较。结果 TLR9mRNA在麻风患者外周血单核细胞中的表达明显高于已痊愈组和正常对照组(P均<0.01),但痊愈组和正常对照组的差异不显著;且TLR4mRNA在麻风现症患者外周血单核细胞中的表达与痊愈组和正常对照组的差异也无统计学意义(P均>0.05)。结论 TLR9mRNA在麻风患者外周血单核细胞的表达明显升高,提示TLR9mRNA可能是麻风杆菌的特异识别受体,TLR9可能参与了机体感染麻风分枝杆菌后的免疫反应。TLR4是否参与了机体感染麻风分枝杆菌后的免疫反应尚有待于进一步论证。 Objective To study the expression of TLR4 and TLR9 mRNA on peripheral blood mononuclear cells (PB- MC ) in patients with leprosy. Methods A total of 90 subjects including 30 with leprosy, 30 recovered from leprosy and 30 normal controls were enrolled in this study. SYBR Green fluorescence quantitative RT-PCR was used to assess the expression of TLR4 and TLR9 mRNA in PBMC of them. Results Expression of TLR9 mRNA in leprosy patients was significantly higher than that in both the recovered and normal controls (P 〈 0.01 ), There was no significant difference between the recovered and normal control (P 〉0.05 ) ; The expression of TLR4 mRNA had no significant difference among leprosy, recovered and normal control ( both P 〉 O. 05). Conclusion The expression of TLR9 mRNA was significantly higher on the PBMC in leprosy patients, suggesting that TLR9 may be the specific recognizing receptor participated the immune response in Mycobacterium leprae. Further studies are required to reveal the mechanism'by which Mycobacterium leprae activates TLR4 mRNA.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2011年第7期503-505,共3页 The Chinese Journal of Dermatovenereology
基金 国家自然科学基金(30960350) 贵州省省长资金[2006,(48)号]
关键词 TOLL样受体4 TOLL样受体9 外周血 麻风 TLR4 TLR9 Peripheral blood Leprosy
  • 相关文献

参考文献11

  • 1Takeda K, Akira S. Toll-like receptors in innate immunity[ J ]. Int Immunnl, 2005, 17( 1 ) :1 - 14.
  • 2鲁东平,刘源,汪治国,张信江,罗丽,付敏.Toll样受体2和4在麻风患者皮损中的表达[J].中国皮肤性病学杂志,2010,24(10):896-898. 被引量:2
  • 3Matsngochi T, Musikaehamen T, Ogawa T, et al. Gene expressions of Toll-like receptor 2,but not Tnll-like receptor4,is induced by LPS and inllammatory eytokines in mouse macrophages[ J]. J Im munul, 2000, 165(10) : 5767 -5772.
  • 4Re F, Stronfinger JL. Toll-like receptor 2 (TLR2) and TI.R4 differenti- ally activale human dendritic cells[ J ]. J Biol Chem, 2001 , 276 (40) :37692 -37699.
  • 5Akashi S, Shimazu R, Ogata 14, et al. MD-2, a molecule that confers lipopolysncharide responsiveness on Toll-like receptor 4 [ J ]. J Exp Med, 1999, 189(11) : 1777 -1782.
  • 6He W. Yu Q, Zhou Z, et al. CpG oligonucleotides induce an immune response of odontoblasls through the TLR9, MyDS8 and NF-kappaB pathways. Bioehem Biophys Res Commun [ J ]. 2010, 399 (2) : 274 - 278.
  • 7Verstrepen L, Adib-Conquy M, Kreike M,et al. Expression of the NF- kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4stimulation is itself regulated by NF-kappaB [ J ]. J Cell Mol Met], 2008, 12( 1 ) : 316 -329.
  • 8Ghosh S, Karin M. Missing pieces in the NF-kappa B puzzle[ J ]. Cell, 2002. 109 (1), 81 -96.
  • 9Janssens S, Bevaert R. Auniversal role for MyD88 in TLR/IL-I recep- tor-mediated signaling[ J ]. Trends Bioehem Sci 2002, 27 (9) : 474 - 482.
  • 10Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation [ J ]. Nature, 1995, 374 (6522) : 546 - 549.

二级参考文献9

  • 1Hashimoto C,Hudson KL,Anderson KV.The Toll gene of Drosophila,equired for dorsal-ventral embryonic polarity,appears to encode a transmembrane protein[J].Cell,1988,52(2):269 -279.
  • 2Chervonsky AV,Medzhitoy RM,Denzin LK,et al.Subtle conformational changes induce in major histocompatibility complex class Ⅱ molecules by binding pestides[J].Proc Natl Acad Sci,1998,95 (17):10094-10097.
  • 3Medzhitov R,Preston-Hurlburt P,Janeway CA.A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J].Nature,1997,388(6640):394-397.
  • 4Musio M,Bosiso D,Polenarutfi N,et al.Differential expression and regulation of Toll-like receptors (TLRs) in human leukcocytes:selective expression of TLRs in dendritic cells[J].Immunol,2000,164:5998-6004.
  • 5Medzhitov R.Toll-like receptors and innate immunity[J].Nat Rev Immunol,2001,1(2):135-145.
  • 6Baker BS,Oviqne JM,Powles AV,et al.Normal keratinocytes express Toll-like receptors (TLRs) 1,2 and 5:modulation of TLR expression in chronic plaque psoriasis[J].Br J Dermatol,2003,148(4):670 -679.
  • 7Krutzik SR,Ochoa MT,Sieling PA,et al.Activation and regulation of Toll-like receptors 2 and 1 in human leprosy[J].Nat Med,2003,9(5):525 -532.
  • 8Hoshino K,Takeuchi O,Kawai T,et al.Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to Lipopoly-saccharide:evidence for TLR4 as the LPS gene product[J].J Immunol,1999,162(7):3749-3752.
  • 9吕成志,Mona Man,张信江,Kenneth R Feingold,Peter M Elias,蔺茂强.TLR2和TLR4在不同皮炎模型皮肤的表达[J].中国皮肤性病学杂志,2009,23(7):390-392. 被引量:4

共引文献1

同被引文献23

  • 1刘慧敏,张瑞英,耿静,张西克,吴平,张合恩,姚贵申.Toll样受体9在SLE患者产生抗dsDNA抗体中的作用[J].中华皮肤科杂志,2007,40(1):25-27. 被引量:5
  • 2丘创华,侯敢,黄迪南.TNF-α信号传导通路的分子机理[J].中国生物化学与分子生物学报,2007,23(6):430-435. 被引量:74
  • 3Marshak-Rothstein A. Toll-like receptors in systemic autoimmune dis- ease[ J]. Nat Rev Immuno1,2006,6( 11 ) :823 - 835.
  • 4Stoppelenburg AJ. Toll-like receptor 9 and Systemic Lupus Erythromato- sus : novel insights [ M ]. Department of Veterinary Medicine ,2012 :! - 23.
  • 5Lindstrom O, Tukiainen E, Kylanpaa L, et 8/. Circulating levels of a soluble form of receptor for advanced glycation end products and high mobility group box ehromosomal protein 1 in patients with acute panere- atitis [ J ]. Pancreas, 2009,38 ( 8 ) : 215 - 220.
  • 6John R Klune, Rajeev Dhupar, Jon Cardinal, et al. HMGB1 :Endoge- nous Danger Signaling[J]. Mol Med, 2008,14 ( 7 -8 ) :476 - 484.
  • 7Popovie PJ, DeMareo R, Lotze MT, et al. High Mobility Group B1 Pro- tein Suppresses the Human Plasmacytoid Dendritic Cell Response to TLR9 Agonists [ J ]. J Imnmno1,2006,177 (12) :8701 - 8707.
  • 8Katherine Miles, Jonathan Heaney, Zaneta Sibinska, et al. A tolero- genic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells[ J]. PNAS,2012,9 (3) : 887 - 892.
  • 9Ghaly NR, Kotb NA, Nagy HM, et al. Toll-like receptor 9 in systemic lupus erythematosus, impact on glueocorticoid treatment. Journal of Dermatological Treatment[J]. Journal of Dermatological Treatment, 2012,8(5) :1 -7.
  • 10Horton CG, Zi-jian Pan, Farris AD. Targeting Toll-Like receptors for treatment of SLE [ J ]. Mediators Inflamm, 2010,2010 ( 19 ) : 1 - 9.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部